About Yikon Genomics
Yikon Genomics is a company based in China founded in 2012. Yikon Genomics has raised $31.26 million across 1 funding round from investors including Bank of Communications, Yuexiu Capital and Zhongyuan Jiupai Fund. Yikon Genomics operates in a competitive market with competitors including MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others.
- Headquarter Changping District, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Yikon Genomics India Private Limited
- Date of Incorporation 21 Apr, 2023
- Jurisdiction Haveli, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$31.26 M (USD)
in 1 rounds
-
Latest Funding Round
$31.26 M (USD), Series C
Nov 04, 2019
-
Investors
Bank of Communications
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Yikon Genomics
Unlock access to complete
Unlock access to complete
Funding Insights of Yikon Genomics
Yikon Genomics has successfully raised a total of $31.26M through 1 strategic funding round. The most recent funding activity was a Series C round of $31.26 million completed in November 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Yikon Genomics
Yikon Genomics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Bank of Communications, Yuexiu Capital and Zhongyuan Jiupai Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Yuexiu Capital is engaged in financial services and asset management.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Commercial bank focused on communication science and technology
|
Locked | Locked | Locked |
Investor details for Yikon Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Yikon Genomics
Investment portfolio details for Yikon Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Yikon Genomics
Detailed financials for Yikon Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Yikon Genomics Comparisons
Peer comparison for Yikon Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Yikon Genomics
Yikon Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Personalis, Veritas Genetics and Burning Rock, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Genetic testing products for health risks and traits are offered.
|
|
| Locked | Locked | Locked |
Personalized cancer diagnostics are developed using genomic big data analysis.
|
|
| Locked | Locked | Locked |
Drug and companion diagnostics for multi-drug resistant cancers are developed.
|
Detailed competitors of Yikon Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Yikon Genomics
Complete news archive for Yikon Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yikon Genomics
Yikon Genomics was founded in 2012 and raised its 1st funding round 7 years after it was founded.
Yikon Genomics is headquartered in China. It is registered at Beijing, China.
Yikon Genomics is a funded company, having raised a total of $31.26M across 1 funding round to date.
Yikon Genomics was founded in 2012 in Changping District, China, within the genomics sector. Next-generation sequencing is applied to deliver non-invasive prenatal testing and liquid biopsy services. A proprietary MALBAC-NGS platform is utilized for targeted DNA amplification. Kits are supplied for pre-implantation genetic testing, SNP-based tumor profiling, HER2 assessment, and BRCA analysis. Liquid biopsy options are also available to support personalized cancer treatments.
Yikon Genomics's top competitors include Foundation Medicine, MedGenome and Personalis.
Yikon Genomics has 4 investors. Key investors include Bank of Communications, Yuexiu Capital, Zhongyuan Jiupai Fund, and Jinhe Capital.